SCHEMBL7414404

SCHEMBL7414404

CC(C)(C)OC(=O)N1CCCC1C/C=C/c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
ALDH1A1 P00352 2/20 0.57
LMNA P02545 1/20 0.57
TSHR P16473 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
OPRD1 P41143 1/20 0.45
KLK7 P49862 1/20 0.45
KDM1A O60341 1/20 0.43
HCRTR2 O43614 1/20 0.42
RIPK1 Q13546 1/20 0.41
MAPT P10636 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
UCHL1 P09936 2/20 0.41
GPR119 Q8TDV5 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
NPC1 O15118 1/20 0.41
HSD17B10 Q99714 1/20 0.40
KDM4E B2RXH2 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7414409 1.00 MEN1 (0.57) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL7816624 0.97 MEN1 (0.54) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL7417065 0.97 MEN1 (0.54) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL7414150 0.89 LMNA (0.46) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL7414152 0.89 LMNA (0.46) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL7415471 0.86 KMT2A (0.44) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL7415474 0.86 KMT2A (0.44) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL7417752 0.85 HRH3 (0.47) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL7417755 0.85 HRH3 (0.47) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL7421448 0.85 ALDH1A1 (0.44) MEN1KMT2AALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0734379-B1 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF PARKE DAVIS (FR) 2001-03-07 EP disclosed
EP-0995436-A2 Ligands for sigma receptors and their therapeutical applications PARKE-DAVIS (FR) 2000-04-26 EP disclosed
US-6013656-A PSYCHOLOGICAL DISORDERS; GASTROINTESTINAL DISORDERS; NERVOUSSYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 2000-01-11 US disclosed
US-5849760-A 2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors INSTITUT DE RECHERCHE JOUVEINAL (FR) 1998-12-15 US disclosed
EP-0734379-A1 NOVEL 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF INSTITUT DE RECHERCHE JOUVEINAL (I.R.J) (FR) 1996-10-02 EP disclosed
WO-1995015948-A1 NOVEL 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF INSTITUT DE RECHERCHE JOUVEINAL (FR) 1995-06-15 WO disclosed